Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

This study is ongoing, but not recruiting participants.
National Cancer Institute (NCI)
Southwest Oncology Group
Bristol-Myers Squibb
Aptuit Inc.
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology Identifier:
First received: December 14, 2005
Last updated: June 17, 2016
Last verified: June 2016